1.
Sen S. Canagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug. JDDT [Internet]. 13May2013 [cited 19Sep.2019];3(3):145-6. Available from: http://www.jddtonline.info/index.php/jddt/article/view/490